Associating liver partition and portal vein ligation for staged hepatectomy in the treatment of colorectal cancer liver metastases

Table 2 Outcome characteristics[25]

Variable	Number of patients	Data completion	Value
Interstage interval, d	468	92%	13 (9–21)
Stage 2 performed, n (%)	510	100%	492 (96)
R0 resection at stage 2, n (%)	302	59%	220 (73)
90-d mortality, n (%)	510	100%	25 (5)
Complications ≥ 3B stage 1, n (%)	501	98%	37 (7)
Complications ≥ 3B stage 2, n (%)	485	95%	100 (21)

The cohort included 510 patients with colorectal liver cancer metastasis who underwent associating liver partition and portal vein ligation for staged hepatectomy during the 10-year period from 2009 to 2019 in 22 international centers. Citation: Petrowsky H, Linecker M, Raptis DA, Kuemmerli C, Fritsch R, Kirimker OE, Balci D, Ratti F, Aldrighetti L, Voskanyan S, Tomassini F, Troisi RI, Bednarsch J, Lurje G, Fard-Aghaie MH, Reese T, Oldhafer KJ, Ghamarnejad O, Mehrabi A, Abraham MET, Truant S, Pruvot FR, Hoti E, Kambakamba P, Capobianco I, Nadalin S, Fernandes ESM, Kron P, Lodge P, Olthof PB, van Gulik T, Castro-Benitez C, Adam R, Machado MA, Teutsch M, Li J, Scherer MN, Schlitt HJ, Ardiles V, de Santibañes E, Brusadin R, Lopez-Lopez V, Robles-Campos R, Malagó M, Hernandez-Alejandro R, Clavien PA. First Long-term oncologic results of the ALPPS procedure in a large cohort of patients with colorectal liver metastases. Annals of surgery 2020; 272: 793-800. Copyright© 2020 Wolters Kluwer Health, Inc.